6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase

Brain Research

Volumn 922, Issue 1, 2001, Pages 51-64

  Kunikowska, Grazyna ^a   Jenner, Peter ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Division of Pharmacology and Therapeutics   (United Kingdom)

Author keywords

6 OHDA lesioned rat; Antioxidant enzyme; Basal ganglia; Parkinson's disease

Indexed keywords

APOMORPHINE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; MAZINDOL; MESSENGER RNA; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG BINDING; DRUG INDUCED DISEASE; FEMALE; GLOBUS PALLIDUS; IN SITU HYBRIDIZATION; NEUROPATHOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; OLIGONUCLEOTIDE PROBE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BASAL GANGLIA; BEHAVIOR, ANIMAL; DNA PROBES; DOPAMINE; FEMALE; GLUTATHIONE PEROXIDASE; IN SITU HYBRIDIZATION; MALE; MAZINDOL; NEOSTRIATUM; NEURAL PATHWAYS; OXIDOPAMINE; RATS; RNA, MESSENGER; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS;

EID: 0035856862     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)03149-3     Document Type: Article

References (70)

1. A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy Body Disease
2. Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyquanine levels in substantia nigra
3. Brain peroxidase and catalase in Parkinson's disease
4. Localization of GAT-1 GABA transporter mRNA in rat striatum: Cellular coexpression with GAD 67 mRNA, GAD 67 immunoreactivity and parvalbumin mRNA
5. Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability
6. NF kappa B-independent transcriptional induction of the human manganous superoxide dismutase gene
7. Developmental study of rat brain glutathione peroxidase and glutathione reductase
8. Regional distribution of glutathione peroxidase in the adult rat brain
9. Superoxide dismutase and Parkinson's disease
10. Over-expression of SOD1 in transgenic rats protects vulnerable neurons against ischaemic damage after global cerebral ischaemia and reperfusion
11. Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase
12. Glutathione peroxidase, glial cells and Parkinson's disease
13. Lipid peroxidation as cause of nigral cell death in Parkinson's disease
14. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
15. Increased levels of lipid hydroperoxides in parkinsonian substantia nigra: A HPLC and ESR study
16. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease
17. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra
18. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay
19. Complete coding sequence of rat tyrosine hydroxylase mRNA
20. Partial lesions of the dopaminergic nigrostriatal system in rat brain: Biochemical characterization
21. Nucleotide sequences of cDNAs coding for rat manganese-containing superoxide dismutase
22. Nucleotide sequence of rat glutathione peroxidase cDNA
23. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease
24. Oxidative stress and the pathogenesis of Parkinson's disease
25. Overexpression of manganese superoxide dismutase protects against mitochondrial-initiated poly(ADP-ribose) polymerase-mediated cell death
26. Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2
27. Glutathione peroxidase activity in Parkinson's disease
28. Brain glutathione peroxidase in neurodegenerative disorders
29. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis
30. Free radical-generated neurotoxicity of 6-hydroxydopamine
31. The relative distribution of Cu/Zn and Mn superoxide dismutase in adult rat brain
32. Regional distribution of superoxide dismutase in rat during post-natal development
33. Genes regulated in human breast cancer cells overexpressing manganese-containing superoxide dismutase
34. An immunohistochemical observation of manganese superoxide dismutase in rat substantia nigra after occlusion of middle cerebral artery
35. Regional and subcellular distribution of superoxide dismutase in brain
36. Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus
37. Superoxide dismutase-like activity in the Parkinson's disease brain
38. An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease
39. Regional distribution of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains
40. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
41. Quantitative features of reactive gliosis following toxicant-induced damage in the CNS
42. Changes in lipid peroxidation, Cu/Zn-superoxide dismutase and its mRNA following an intracerebroventricular injection of 6-hydroxydopamine in mice
43. Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: Histochemical and neurochemical analysis
44. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons
45. Parkinson's disease: A disorder due to nigral glutathione deficiency?
46. Superoxide dismutase expression in Parkinson's disease
47. Isolation and nucleotide sequence of rat Cu/Zn superoxide dismutase cDNA clones
48. Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains
49. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra
50. Superoxide dismutase and glutathione peroxidase activities in rat brain
51. Evidence for mitochondrial dysfunction in Parkinson's disease - A critical appraisal
52. Intracerebral grafting of neuronal cell suspension implants assessed by measurements of dopamine synthesis and metabolism
53. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
54. Glutathione-related enzymes in Parkinson's disease
55. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains
56. The immunocytochemical demonstration of copper-zinc superoxide dismutase in the brain
57. Distribution of superoxide dismutase in rat brain
58. Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration
59. Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain
60. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system
61. An immunohistochemical study of the neuronal expression of manganese superoxide dismutase in sporadic amyotrophic lateral sclerosis
62. Expression of manganese superoxide dismutase is not altered in transgenic mice with elevated level of copper-zinc superoxide dismutase
63. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice
64. An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease
65. Immunohistochemical detection of hydroxynonenal protein adducts in Parkinson's disease
66. Cerebrospinal fluid levels of superoxide dismutases in neurological disease detected by sensitive enzyme immunoassays
67. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in increased iron and melanin induced neurodegeneration?
68. Distribution of manganese-dependent superoxide dismutase in the human brain
69. Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon